Filing Flows › Core Laboratories (CLB) › Capital expenditures
Core Laboratories (CLB) capital expenditures by quarter
Core Laboratories' capital expenditures were $3.2M in Q3 2026 (third quarter 2026), -31% from Q2 2026. Over the last 7 quarters it ranged from $2.0M (Q3 2025) to $4.7M (Q2 2026).
| Quarter | Capital expenditures | Q/Q | Y/Y |
|---|---|---|---|
| Q3 2026 | $3.2M | -31% | +62% |
| Q2 2026 | $4.7M | +36% | +35% |
| Q1 2026 | $3.4M | +17% | +24% |
| Q4 2025 | $2.9M | +47% | — |
| Q3 2025 | $2.0M | -42% | — |
| Q2 2025 | $3.5M | +25% | — |
| Q1 2025 | $2.8M | — | — |
Q3 2026 at a glance
Core Laboratories, Q3 2026: revenue $132M (-2% year over year), operating margin 9.1%, net earnings $5.4M, operating cash flow $5.0M. The chart follows the revenue to costs, profit and cash.
Questions
What is Core Laboratories' capital expenditures?
Core Laboratories' capital expenditures were $3.2M in Q3 2026 (third quarter 2026), -31% from Q2 2026.
How has Core Laboratories' capital expenditures changed?
Over the last 7 quarters it ranged from $2.0M (Q3 2025) to $4.7M (Q2 2026).